Probiotic supplementation and systemic inflammation in relapsing-remitting multiple sclerosis: A randomized, double-blind, placebo-controlled trial (vol 16, 901846, 2022)

被引:1
|
作者
Rahimlou, Mehran [1 ,2 ]
Nematollahi, Shima [1 ]
Husain, Durdana [1 ]
Banaei-Jahromi, Nasrin [3 ]
Majdinasab, Nastaran [4 ]
Hosseini, Seyed Ahmad [1 ]
机构
[1] Ahvaz Jundishapur Univ Med Sci, Clin Sci Res Inst, Nutr & Metab Dis Res Ctr, Ahvaz, Iran
[2] Zanjan Univ Med Sci, Fac Med, Dept Nutr, Zanjan, Iran
[3] Ahvaz Jundishapur Univ Med Sci, Sch Allied Med Sci, Dept Nutr, Ahvaz, Iran
[4] Ahvaz Jundishapur Univ Med Sci, Sch Med, Dept Neurol, Ahvaz, Iran
关键词
probiotic; multiple sclerosis; inflammation; clinical trial; gut microbiome;
D O I
10.3389/fnins.2022.1085572
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
引用
收藏
页数:2
相关论文
共 50 条
  • [1] Probiotic supplementation and systemic inflammation in relapsing-remitting multiple sclerosis: A randomized, double-blind, placebo-controlled trial
    Rahimlou, Mehran
    Nematollahi, Shima
    Husain, Durdana
    Banaei-Jahromi, Nasrin
    Majdinasab, Nastaran
    Hosseini, Seyed Ahmad
    FRONTIERS IN NEUROSCIENCE, 2022, 16
  • [2] A double-blind, placebo-controlled, randomized trial of cladribine in relapsing-remitting multiple sclerosis
    Romine, JS
    Sipe, JC
    Koziol, JA
    Zyroff, J
    Beutler, E
    PROCEEDINGS OF THE ASSOCIATION OF AMERICAN PHYSICIANS, 1999, 111 (01) : 35 - 44
  • [3] Acyclovir treatment of relapsing-remitting multiple sclerosis - A randomized, placebo-controlled, double-blind study
    Lycke, J
    Svennerholm, B
    Hjelmquist, E
    Frisen, L
    Badr, G
    Andersson, M
    Vahlne, A
    Andersen, O
    JOURNAL OF NEUROLOGY, 1996, 243 (03) : 214 - 224
  • [4] The effects of ginger supplementation on common gastrointestinal symptoms in patients with relapsing-remitting multiple sclerosis: a double-blind randomized placebo-controlled trial
    Foshati, Sahar
    Poursadeghfard, Maryam
    Heidari, Zahra
    Amani, Reza
    BMC COMPLEMENTARY MEDICINE AND THERAPIES, 2023, 23 (01)
  • [5] The effects of ginger supplementation on common gastrointestinal symptoms in patients with relapsing-remitting multiple sclerosis: a double-blind randomized placebo-controlled trial
    Sahar Foshati
    Maryam Poursadeghfard
    Zahra Heidari
    Reza Amani
    BMC Complementary Medicine and Therapies, 23
  • [6] A placebo-controlled, randomized, double-blind, MRI trial of antiherpes therapy in patients with relapsing-remitting multiple sclerosis (RRMS)
    Jakobsen, J
    Bech, E
    Gadeberg, P
    Hansen, HJ
    Christensen, T
    Haahr, S
    Hollsberg, P
    Lycke, J
    Malmestrom, C
    Ekholm, S
    Bergstrom, T
    Svennerholm, B
    Andersen, O
    NEUROLOGY, 2001, 56 (08) : A74 - A74
  • [7] A randomized double-blind placebo-controlled trial of low-dose interleukin-2 in relapsing-remitting multiple sclerosis
    Louapre, C.
    Rosenzwajg, M.
    Golse, M.
    Roux, A.
    Pitoiset, F.
    Adda, L.
    Tchitchek, N.
    Papeix, C.
    Maillart, E.
    Ungureanu, A.
    Charbonnier-Beaupel, F.
    Galanaud, D.
    Corvol, J. C.
    Vicaut, E.
    Lubetzki, C.
    Klatzmann, D.
    JOURNAL OF NEUROLOGY, 2023, 270 (09) : 4403 - 4414
  • [8] Efficacy and Safety of Tabalumab in Patients with Relapsing-Remitting Multiple Sclerosis: A Randomized, Double-Blind, Placebo-Controlled Study
    Silk, Maria
    Nantz, Eric
    NEUROLOGY, 2018, 90
  • [9] A double-blind, placebo-controlled, multicentre study to evaluate dirucotide in relapsing-remitting multiple sclerosis
    Selmaj, K.
    Verco, T.
    Ossanna, M.
    Nilsson, M.
    Ferenczi, L.
    Chappell, A.
    Arfors, L.
    MULTIPLE SCLEROSIS, 2009, 15 (09): : S235 - S235
  • [10] Epigallocatechin Gallate in Relapsing-Remitting Multiple Sclerosis A Randomized, Placebo-Controlled Trial
    Bellmann-Strobl, Judith
    Paul, Friedemann
    Wuerfel, Jens
    Doerr, Jan
    Infante-Duarte, Carmen
    Heidrich, Elmira
    Koertgen, Benedict
    Brandt, Alexander
    Pfuller, Caspar
    Radbruch, Helena
    Rust, Rebekka
    Siffrin, Volker
    Aktas, Orhan
    Heesen, Christoph
    Faiss, Juergen
    Hoffmann, Frank
    Lorenz, Mario
    Zimmermann, Benno
    Groppa, Sergiu
    Wernecke, Klaus-Dieter
    Zipp, Frauke
    NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION, 2021, 8 (03):